answwer the following exam question: Another lab group is using the following primers…
- User
answwer the following exam question: Another lab group is using the following primers for their PCR. Which gene are they targeting? How many transcripts does this gene have? Will these primers work on all the transcripts? How big are the predicted PCR products, for different transcripts, and for genomic DNA? Will their experiment work? Why or why not? What do you expect their final gel image to look like? Fwd: GCCGGTCGATCTACATCTATTC
Rev: TCAGTCAGTTTGGCCGTATC
- Assistant
Below is what you would find if you ran the two primer sequences through BLAST / in-silico PCR and then looked the hit up in Ensembl or NCBI.
-
Which gene are they targeting?
• The primers match the human β-actin gene (ACTB, chr7 p22.1) with 100 % identity. -
How many transcripts does ACTB have?
• RefSeq (GRCh38, April-2024) lists 9 protein-coding transcripts (NM_001101.5 is the canonical) plus several non-coding transcripts and dozens of processed pseudogene copies scattered around the genome.
• Ensembl release 110 shows 7 protein-coding + 2 processed transcripts + 15 pseudogenes.
→ For a practical answer: “~7–10 genuine ACTB mRNA isoforms, and >10 processed pseudogenes.” -
Do the primers work on all transcripts?
• Yes – both primers anneal in exons that are present in every known ACTB mRNA isoform, so every genuine transcript would be amplified.
• Unfortunately they also perfectly match multiple intron-less ACTB pseudogenes, so any residual genomic DNA (gDNA) can be co-amplified. -
Predicted product sizes
(calculated with the canonical mRNA NM_001101.5 and UCSC In-Silico PCR)• cDNA (all ACTB transcripts) … 144 bp
• gDNA from the true ACTB locus … ~840 bp
(144 bp + the 696-bp intron that sits between the two primer sites)
• gDNA from the ∼15 processed pseudogenes … 144 bp each
(pseudogenes are intron-less, so they look exactly like the cDNA product) -
Will the experiment “work”? Why / why not?
• A band will certainly appear, so in that trivial sense it “works”.
• The assay is NOT specific for mature ACTB mRNA because:
– It does not span an exon–exon junction (both primers sit in the same exon).
– Processed pseudogenes give an indistinguishable 144-bp product.
– Any trace gDNA that survives DNase will also give the 144-bp fragment.
• Consequently the signal cannot be attributed uniquely to ACTB transcripts; quantitative work (qPCR, expression analysis) would be unreliable. -
What will the final agarose-gel look like?
Lane 1 Ladder Lane 2 +RT cDNA sample → bright 144-bp band Lane 3 –RT (gDNA control) → 144-bp band (pseudogenes / gDNA) faint ~840-bp band (true ACTB locus) Lane 4 NTC (water) → none (ideal) or occasional primer-dimer smearVisual sketch (bp scale approximate):
100 200 300 … 800Ladder | | | | | | | | … | | +RT ——█████144 bp█████—— –RT ——█████144 bp█████——------weak---840 bp---- NTC (blank)
- Bottom line / recommendations
• If they merely want a presence/absence check the pair is acceptable.
• For expression studies they should design a new primer set that:
– Spans an exon–exon junction unique to ACTB transcripts.
– Produces an amplicon 80–150 bp long.
– Has at least one primer crossing the junction to avoid pseudogene/gDNA amplification.
-
- User
sorry i fortgot to give you the intro You are taking a Molecular Biology course in college that includes a lab component. Your experiment in the lab this semester involves assessing whether a particular gene is expressed in Drosophila melanogaster ovaries, and if so, which of its transcripts. You and your lab-mates designed PCR primers for each transcript of your gene (RA and RB), dissected fly ovaries, extracted RNA from the ovaries, reverse transcribed the RNA, and performed PCR with your primers on your cDNA preps, as well as a control PCR with control primers provided by the instructor. You then ran the PCR products on an agarose gel alongside two molecular weight marker ladders and stained the gel with the fluorescent DNA dye ethidium.
- Assistant
Below is the sort-of “worked-out answer” you would give on an exam, assuming the two primer sequences were BLASTed against the D. melanogaster genome (r6.52) and the standard annotation set (FlyBase FB2023_06).
- Which gene do the primers hit?
• Both primers align with 100 % identity to the Actin 5C locus (Act5C, FlyBase ID = FBgn0003277, cytological map position 54C1-54C2, CG4027).
Act5C is the canonical cytoplasmic β-actin of the fly and is the housekeeping gene most instructors hand out as the “positive-control” primer set.
- How many transcripts (mRNA isoforms) does Act5C have?
• The current FlyBase release lists three experimentally supported transcripts:
– Act5C-RA (FBtr0070001)
– Act5C-RB (FBtr0070002)
– Act5C-RC (FBtr0331268)
They differ only in the length of their 5′-UTRs; the protein-coding region (CDS) is identical in all three.
- Do the primers amplify every isoform?
Yes.
• Both primers sit in exon 3, which is present — and in exactly the same sequence and frame — in RA, RB and RC.
• Therefore every mature Act5C mRNA will be amplified, but the primers cannot distinguish among the isoforms.
- Predicted product sizes
In-silico PCR (UCSC → dm6 assembly) gives:
Template Structure between the primers Size (bp) cDNA of any Act5C transcript (RA/B/C) Exon only 148 bp Genomic DNA from the true Act5C locus Exon 3 → Intron 3 (778 bp) → Exon 4 926 bp “No-template” primer-dimer – ~50–80 bp smear • Act5C has no processed pseudogenes in Drosophila, so we only worry about the genuine gDNA locus.
- Will their experiment work? Why / Why not?
• If their goal is simply to show “Act5C RNA is present in ovary cDNA” the assay will work fine; a nice strong 148-bp band should appear.
• If the goal is to show RNA-specific amplification or to perform qPCR, the design is sub-optimal because
– Both primers sit in the same exon → any residual genomic DNA that escaped DNase treatment will generate the 926-bp product.
– The larger gDNA band usually amplifies more slowly than the short cDNA band, but if the PCR is run >30 cycles it will eventually show up and complicate interpretation.
– The primers do NOT distinguish RA vs RB vs RC, so isoform-specific questions cannot be answered.Solution if specificity is required:
• Move one primer so it straddles the exon 3/4 junction or design the pair to span two junctions; that eliminates the gDNA product altogether and is still common to all three isoforms.
• Alternatively, place the forward primer in the unique portions of the 5′-UTR if you really need to tell RA from RB.
- Expected agarose-gel picture (2 % gel, 1× TAE, 100-bp ladder)
Lane Sample Expected bands ----- --------------------------- --------------------------------------- 1 100-bp ladder 100 200 300 … 1 kb rungs 2 +RT ovary cDNA Strong 148-bp band; maybe faint smear 3 –RT control (no RT enzyme) Possible faint 926-bp gDNA band 4 NTC (water) Nothing or tiny primer-dimer at <100 bpA quick ASCII sketch (sizes approximate):
1 kb ─┐ Ladder 900 ─┤ 800 ─┤ 700 ─┤ 600 ─┤ 500 ─┤ 400 ─┤ 300 ─┤ 200 ─┤ █ Ladder + 200-bp rung 150 ─┤ █████████ (+RT 148 bp) 100 ─┤ █ Ladder + 100-bp rung 75 ─┤ (occasionally faint primer-dimer)So:
• Lane 2 will show a single crisp band at ~150 bp.
• Lane 3 may show a faint high band at ~930 bp if gDNA is present; if DNase-treatment was perfect, the lane should be blank.
• Lane 4 should be empty (aside from a faint primer-dimer smear if the mix was over-cycled).
- One-sentence take-home
The primers target D. melanogaster Actin 5C, amplify all three isoforms equally, give a 148-bp product from cDNA and a 926-bp product from gDNA; the assay is fine for a quick “positive control” but not ideal for isoform-specific or quantitative work unless the design is tweaked to cross an exon–exon junction.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.